Latest News
Norfolk Southern Faces Headwinds from Fuel Costs and Merger Uncertainty
Norfolk Southern reported a 27% drop in Q1 net income to $547 million, weighed by higher fuel costs and merger expenses. Shares slipped 0.5% as investors focused on cost pressures and weak freight volumes.
Synopsys Deepens TSMC Alliance for AI Chip Design Tools
Synopsys announced expanded collaboration with TSMC on advanced chipmaking and packaging for AI, unveiling new design tools for 3nm, 2nm, A16, and A14 nodes. Shares rose to $483.00.
Organon Surges on Report of $13B Sun Pharma Bid
Organon shares jumped 25% Friday after a report that Sun Pharma made a $13 billion all-cash takeover offer, backed by $12 billion in bank financing.
Joby Aviation Partners on LA Rooftop Vertiport, Awaits FAA Certification
Joby Aviation and Reuben Brothers plan an air-taxi vertiport at LA's Century Plaza, using an existing helipad. The project awaits local, state, and federal approvals as Joby pursues commercial certification.
MaxLinear Soars 67% on AI Data-Center Chip Demand, Upbeat Forecast
MaxLinear shares jumped 67% after Q1 revenue beat estimates and Q2 guidance topped expectations, fueled by AI data-center optical chip demand.
Qualcomm Rallies Ahead of Earnings, AI Sector Faces Pivotal Week
Qualcomm shares jumped 9.7% ahead of its April 29 earnings report, but JPMorgan downgraded the stock citing smartphone and data-center challenges. Adobe announced a $25B buyback as it pivots to AI.
American Express Shares Dip Despite Q1 Profit Beat as Travel Spending Worries Mount
American Express reported Q1 EPS of $4.28, up 18%, and revenue of $18.9 billion, but shares fell 4.3% as investors focused on rising costs and weaker airline spending.
X-Energy's $1B IPO Fuels Nuclear Renaissance for AI Power Needs
X-Energy raised $1.02 billion in an upsized IPO, pricing shares 21% above the range. The small modular reactor developer, backed by Amazon, targets AI and data center energy needs.
Regeneron Stock Rises on Drug Pricing Deal, Free Gene Therapy Offer
Regeneron shares gained 2.6% Thursday following a drug-pricing pact with the U.S. and a plan to offer its new gene therapy Otarmeni at no cost. Analysts remain optimistic ahead of Q1 results.
P&G Tops Q3 Estimates, Flags $150M Commodity Hit on Fiscal 2026
Procter & Gamble reported fiscal Q3 net sales of $21.2 billion and core EPS of $1.59, beating estimates. The company warned of a $150 million cost hit from commodities and tariffs in fiscal 2026.
IREN's AI Pivot Faces Key Test as Q3 Earnings, Microsoft Deal Loom
IREN Limited reports fiscal Q3 earnings on May 7, with investors focused on AI data center expansion, a $9.7 billion Microsoft deal, and $6 billion share dilution risk.